Skip to main content

Clinical Trials › NCT05286242

Active, Not Recruiting

Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients

Sponsored by Yale University

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
400
Target enrollment
1
U.S. states
Feb 2021
Start date
Jun 2026
Expected completion

Interventions / Treatments

COVID19 vaccine

Conditions studied

Multiple Sclerosis

Where this trial is running (1 site)

New Haven

MS centers in Connecticut

Compare treatment centers near a trial site by center type, providers and trials.

View Connecticut centers
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play